ASPICon2023 will run on the theme “Precision Clinical Pharmacology: Future of Rational Therapeutics”. A rising number of adverse drug reactions (ADRs) has led to unplanned hospital admission or readmission of patients, with a drug–drug interaction suspected in many cases. Therefore, significant efforts are being made to refine personalized, precise, predictive, and participatory therapeutic strategies that can be systematically defined as precision or personalized medicine. The adoption of precision medicine practices in hospitals requires the interaction of different medical disciplines, including clinical pharmacology.
The American College of Clinical Pharmacology defines clinical pharmacology as the promotion of the rational use of medications in humans by studying their restorative effect, to amplify the effect of drugs, and reduce their side effects. Therefore, from this perspective, clinical pharmacologists bridge the gap between science and the practice of medicine through innovative research, development, and regulation of medications. Clinical pharmacology pursues the optimal use of drugs by applying the provisions of personalized pharmacotherapy, taking into consideration the factors that have an influence on the interindividual variation of drug response.